The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer-Reference-Cited by-同舟云学术

The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer

Published:2017-03-16 Issue:15 Volume:123 Page:2945-2954
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jacobs Bruce L.¹²,Yabes Jonathan G.²³,Lopa Samia H.¹,Heron Dwight E.⁴,Chang Chung-Chou H.³⁵,Schroeck Florian R.⁶,Bekelman Justin E.⁷⁸⁹,Kahn Jeremy M¹⁰,Nelson Joel B.¹,Barnato Amber E.²³¹¹

Affiliation:

1. Department of Urology; University of Pittsburgh; Pittsburgh Pennsylvania

2. Center for Research on Health Care; University of Pittsburgh; Pittsburgh Pennsylvania

3. Division of General Internal Medicine, Department of Medicine; University of Pittsburgh; Pittsburgh Pennsylvania

4. Department of Radiation Oncology; University of Pittsburgh; Pittsburgh Pennsylvania

5. Department of Biostatistics, Graduate School of Public Health; University of Pittsburgh; Pittsburgh Pennsylvania

6. White River Junction Veterans Affairs Medical Center and The Dartmouth Institute Geisel School of Medicine; Lebanon New Hampshire

7. Department of Radiation Oncology, Division of General Internal Medicine; University of Pennsylvania; Philadelphia Pennsylvania

8. Abramson Cancer Center; University of Pennsylvania; Philadelphia Pennsylvania

9. Leonard Davis Institute of Health Economics; University of Pennsylvania; Philadelphia Pennsylvania

10. Department of Critical Care Medicine; University of Pittsburgh; Pittsburgh Pennsylvania

11. Department of Health Policy Management, Graduate School of Public Health; University of Pittsburgh; Pittsburgh Pennsylvania

Funder

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

National Institute on Aging

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Analysis of biochemical control and prognostic factors in patients treated with either low-dose 3-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer;Vora;Int J Radiat Oncol Biol Phys,2007

2. Incidence of late rectal and urinary toxicities after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer;Zelefsky;Int J Radiat Oncol Biol Phys,2008

3. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity;Jani;Urology,2006

4. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee;Buyyounouski;Int J Radiat Oncol Biol Phys,2010

5. Stereotactic body radiotherapy for low-risk prostate cancer: 5-year outcomes [serial online];Freeman;Radiat Oncol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns;Urology;2024-08

2. Outcomes in studies regarding older patients with prostate cancer: A systematic review;Journal of Geriatric Oncology;2024-06

3. When Patience is a Failing: The Case for Patient Reported Outcomes Adoption;International Journal of Radiation Oncology*Biology*Physics;2023-07

4. Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer;Frontiers in Oncology;2021-02-25

5. Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States;World Neurosurgery;2020-12